Back to HomeBeta

ICD-10 Coding for Fibrocystic Breast(N60.19, N60.3)

Complete ICD-10-CM coding and documentation guide for Fibrocystic Breast. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Fibrocystic DiseaseCystic MastopathyFibroadenosisFibrosclerosis

Related ICD-10 Code Ranges

Complete code families applicable to Fibrocystic Breast

N60-N64Primary Range

Benign mammary dysplasias

This range includes all benign breast conditions, including fibrocystic changes.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
N60.19Diffuse cystic mastopathyUse for generalized fibrocystic changes with multiple cysts, confirmed by imaging and pathology.
  • Imaging confirmation of multiple cysts
  • Pathology confirmation of non-proliferative changes
N60.3FibrosclerosisUse when documentation specifies dominant stromal fibrosis.
  • Pathology confirmation of dense collagenous stroma

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for fibrocystic breast

Essential facts and insights about Fibrocystic Breast

The ICD-10 code for fibrocystic breast is N60.19, used for diffuse cystic mastopathy confirmed by imaging and pathology.

Primary ICD-10-CM Codes for fibrocystic breast

Diffuse cystic mastopathy
Billable Code

Decision Criteria

clinical Criteria

  • Presence of multiple cysts confirmed by imaging

documentation Criteria

  • Pathology report confirming non-proliferative changes

Applicable To

  • Bilateral fibrocystic changes
  • Multiple cysts

Excludes

Clinical Validation Requirements

  • Imaging confirmation of multiple cysts
  • Pathology confirmation of non-proliferative changes

Code-Specific Risks

  • Misclassification due to lack of imaging confirmation
  • Use of outdated terminology

Coding Notes

  • Ensure laterality is documented and avoid using unspecified codes.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Mastodynia

N64.59
Use when documenting associated breast pain.

Encounter for breast screening

Z01.81
Use when fibrocystic changes are discovered during routine screening.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Fibrosclerosis

N60.3
Use when stromal fibrosis is dominant and confirmed by pathology.

Fibroadenosis

N60.29
Use when glandular hyperplasia is present without cysts.

Diffuse cystic mastopathy

N60.19
Use when multiple cysts are present rather than stromal fibrosis.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Fibrocystic Breast to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code N60.19.

Impact

Clinical: May lead to miscommunication among healthcare providers., Regulatory: Non-compliance with current coding standards., Financial: Potential for denied claims due to lack of specificity.

Mitigation Strategy

Use current terminology such as 'diffuse cystic mastopathy'.

Impact

Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with specificity requirements., Data Quality: Decreases accuracy of clinical data.

Mitigation Strategy

Ensure imaging and pathology confirm specific diagnosis to use N60.19 or N60.3.

Impact

Failure to document laterality can lead to audit issues.

Mitigation Strategy

Ensure laterality is documented in all clinical notes and imaging reports.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Fibrocystic Breast, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Fibrocystic Breast

Use these documentation templates to ensure complete and accurate documentation for Fibrocystic Breast. These templates include all required elements for proper coding and billing.

Routine Breast Exam with Fibrocystic Changes

Specialty: Gynecology

Required Elements

  • Breast consistency
  • Tenderness
  • Imaging correlation
  • Pathology confirmation

Example Documentation

Breast Exam: Consistency: Nodular, Tenderness: Cyclic, Imaging: Ultrasound shows multiple cysts, Pathology: Core biopsy confirms non-proliferative changes.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Breast cysts - follow up in 6 months.
Good Documentation Example
34F presents with bilateral breast nodularity. Ultrasound reveals multiple small cysts. Core biopsy shows stromal fibrosis. Diagnosis: Diffuse cystic mastopathy (N60.19).
Explanation
The good example includes laterality, imaging, and pathology confirmation, meeting documentation requirements.

Need help with ICD-10 coding for Fibrocystic Breast? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more